On July 27, Infleqtion rose 8.7% in regular trading, trading at $9.94/share, with turnover of $15.65 million. The rally was driven by continued momentum from the company's recent award of three US Department of Energy Genesis Mission project contracts.

The DOE projects involve collaborations with Argonne National Laboratory, Brookhaven National Laboratory, Lawrence Livermore National Laboratory, and the University of Colorado Boulder, focusing on AI-optimized quantum circuit design for nuclear applications, deployable atomic quantum sensing, and nuclear fusion energy research. The Phase I awards aim to build a foundation for future investment and scale by designing research workflows that integrate AI with scientific investigation.

Multiple catalysts have supported buying interest. The company previously signed a $100 million CHIPS investment letter of intent with the US Department of Commerce to accelerate US quantum computing leadership. Analyst coverage has also been supportive, with Wedbush initiating at outperform with a $20 price target citing the stock as meaningfully mispriced relative to quantum peers, and Canaccord Genuity initiating at buy with a $22 target.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)